NOTES TO CONDENSED FINANCIAL STATEMENTS
DECEMBER 31, 2020
(Unaudited)
NOTE
1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
DD3 Acquisition Corp.
II (the “Company”) was incorporated in Delaware on September 30, 2020. The Company was formed for the purpose of entering
into a merger, capital stock exchange, asset acquisition, stock purchase, recapitalization, reorganization or similar business
combination with one or more businesses or entities (a “Business Combination”).
The Company is not
limited to a particular industry or geographic region for purposes of consummating a Business Combination. The Company is an early
stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging
growth companies.
As of December 31,
2020, the Company had not commenced any operations. All activity for the period from September 30, 2020 (inception) through December
31, 2020 relates to the Company’s formation and its initial public offering (“Initial Public Offering”), which
is described below. The Company will not generate any operating revenues until after the completion of its initial Business Combination,
at the earliest. The Company will generate non-operating income in the form of interest income from the proceeds derived from the
Initial Public Offering.
The registration statements
for the Company’s Initial Public Offering were declared effective on December 7, 2020. On December 10, 2020, the Company
consummated the Initial Public Offering of 12,500,000 units (the “Units” and, with respect to the shares of Class A
common stock included in the Units sold, the “Public Shares”), which includes the partial exercise by the underwriters
of their over-allotment option in the amount of 1,500,000 Units, at $10.00 per Unit, generating gross proceeds of $125,000,000,
which is described in Note 3.
Simultaneously with
the closing of the Initial Public Offering, the Company consummated the sale of an aggregate of 370,000 units (each, a “Private
Unit” and, collectively, the “Private Units”) at a price of $10.00 per Private Unit in a private placement to
DD3 Sponsor Group, LLC (the “Sponsor”) and the Forward Purchase Investors (as defined in Note 4), generating gross
proceeds of $3,700,000, which is described in Note 4.
Transaction
costs amounted to $2,966,508, consisting of $2,500,000 of underwriting fees and $466,508 of other offering costs. In addition,
on December 10, 2020, cash of $743,292 was held outside of the Trust Account (as defined below) and is available for the payment
of offering costs and for working capital purposes.
Following the closing
of the Initial Public Offering on December 10, 2020, an amount of $125,000,000 ($10.00 per Unit) from the net proceeds of the sale
of the Units in the Initial Public Offering and the sale of the Private Units was placed in a trust account (the “Trust Account”),
located in the United States and invested only in U.S. government securities, within the meaning set forth in Section 2(a)(16)
of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 185 days
or less or in any open-ended investment company that holds itself out as a money market fund selected by the Company meeting the
conditions of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the completion
of a Business Combination and (ii) the distribution of the funds in the Trust Account, as described below.
The Company’s
management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and
the sale of Private Units, although substantially all of the net proceeds are intended to be applied generally toward consummating
a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The
Company must complete a Business Combination with one or more target businesses that together have an aggregate fair market value
of at least 80% of the assets held in the Trust Account (excluding taxes payable on interest earned on the Trust Account) at the
time of the agreement to enter into a Business Combination. The Company will only complete a Business Combination if the post-transaction
company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest
in the target sufficient for it not to be required to register as an investment company under the Investment Company Act.
The
Company will provide its holders of the outstanding Public Shares (the “public stockholders”) with the opportunity
to convert all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection
with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as
to whether the Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the
Company, solely in its discretion. The public stockholders will be entitled to convert their Public Shares for a pro rata portion
of the amount then in the Trust Account (initially anticipated to be $10.00 per Public Share, plus any pro rata interest earned
on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). There will be no
conversion rights upon the completion of a Business Combination with respect to the Company’s warrants.
DD3 ACQUISITION CORP. II
NOTES TO CONDENSED FINANCIAL STATEMENTS
DECEMBER 31, 2020
(Unaudited)
The Company will proceed
with a Business Combination only if the Company has net tangible assets of at least $5,000,001 either immediately prior to or upon
such consummation of a Business Combination and, if the Company seeks stockholder approval, a majority of the shares voted are
voted in favor of the Business Combination. If a stockholder vote is not required by law and the Company does not decide to hold
a stockholder vote for business or other reasons, the Company will, pursuant to its Amended and Restated Certificate of Incorporation
(the “Amended and Restated Certificate of Incorporation”), conduct the redemptions pursuant to the tender offer rules of
the U.S. Securities and Exchange Commission (“SEC”) and file tender offer documents with the SEC prior to completing
a Business Combination. If, however, stockholder approval of the transaction is required by law, or the Company decides to obtain
stockholder approval for business or other reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation
pursuant to the proxy rules and not pursuant to the tender offer rules. If the Company seeks stockholder approval in connection
with a Business Combination, the Company’s Sponsor, initial stockholders, officers and directors have agreed to vote their
Founder Shares (as defined in Note 5), Private Shares (as defined in Note 4) and any Public Shares purchased during or after
the Initial Public Offering in favor of approving a Business Combination. Additionally, each public stockholder may elect to convert
their Public Shares irrespective of whether they vote for or against the proposed transaction or do not vote at all.
If the Company seeks
stockholder approval of a Business Combination and it does not conduct conversions pursuant to the tender offer rules, the Amended
and Restated Certificate of Incorporation provides that a public stockholder, together with any affiliate of such stockholder or
any other person with whom such stockholder is acting in concert or as a “group” (as defined under Section 13
of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from converting its shares
with respect to more than an aggregate of 15% or more of the Public Shares, without the prior consent of the Company.
The Company’s
Sponsor, initial stockholders, officers and directors have agreed (a) to waive their conversion rights with respect to any
Founder Shares, Private Shares and Public Shares held by them in connection with the completion of a Business Combination or any
amendment to the Amended and Restated Certificate of Incorporation prior thereto and (b) not to propose an amendment to the
Amended and Restated Certificate of Incorporation (i) to modify the substance or timing of the Company’s obligations with
respect to conversion rights as described in the Company’s final prospectus for its Initial Public Offering or (ii) with
respect to any other provision relating to stockholders’ rights or pre-initial Business Combination activity, unless the
Company provides the public stockholders with the opportunity to convert their Public Shares upon approval of any such amendment
at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest (which
interest shall be net of taxes payable), divided by the number of then outstanding Public Shares.
The
Company will have until December 10, 2022 to complete a Business Combination (the “Combination Period”). If the Company
is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except
for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem
the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account including
interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations,
divided by the number of then outstanding Public Shares, which redemption will completely extinguish public stockholders’
rights as stockholders (including the right to receive further liquidating distributions, if any), and (iii) as promptly
as reasonably possible following such redemption, subject to the approval of the Company’s remaining stockholders and the
Company’s board of directors, dissolve and liquidate, subject in each case to the Company’s obligations under Delaware
law to provide for claims of creditors and the requirements of other applicable law. There will be no conversion rights or liquidating
distributions with respect to the Company’s warrants, which will expire worthless if the Company fails to complete a Business
Combination within the Combination Period.
The
Company’s Sponsor, initial stockholders, officers and directors have agreed to waive their liquidation rights with respect
to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the Company’s
Sponsor, initial stockholders, officers or directors acquire Public Shares in or after the Initial Public Offering, such Public
Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to complete a Business Combination
within the Combination Period. In the event of such distribution, it is possible that the per share value of the assets remaining
available for distribution will be less than the Initial Public Offering price per Unit ($10.00).
In
order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent
any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which
the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below (1)
$10.00 per Public Share or (2) the actual amount per Public Share held in the Trust Account as of the date of the liquidation
of the Trust Account due to reductions in the value of the trust assets, in each case net of the interest which may be withdrawn
to pay the Company’s taxes. This liability will not apply with respect to any claims by a third party who executed a waiver
of any and all rights to seek access to the Trust Account and except as to any claims under the Company’s indemnity of the
underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933,
as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against
a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will
seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring
to have all vendors, service providers (except the Company’s independent registered public accounting firm), prospective
target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right,
title, interest or claim of any kind in or to monies held in the Trust Account.
DD3 ACQUISITION CORP. II
NOTES TO CONDENSED FINANCIAL STATEMENTS
DECEMBER 31, 2020
(Unaudited)
Risks
and Uncertainties
Management
is currently evaluating the impact of the COVID-19 pandemic on the industry and has concluded that while it is reasonably possible
that the virus could have a negative effect on the Company’s financial position, results of its operations and/or search
for a target company, the specific impact is not readily determinable as of the date of the financial statements. The financial
statements do not include any adjustments that might result from the outcome of this uncertainty.
NOTE
2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis
of Presentation
The
accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted
in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions
to Form 10-Q and Article 10 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included
in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations
of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a
complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying
unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary
for a fair presentation of the financial position, operating results and cash flows for the periods presented.
The accompanying unaudited
condensed financial statements should be read in conjunction with the Company’s final prospectus for its Initial Public Offering
as filed with the SEC on December 10, 2020, as well as the Company’s Current Reports on Form 8-K, as filed with the
SEC on December 11, 2020 and December 16, 2020. The interim results for the three months ended December 31, 2020 and for the period
from September 30, 2020 (inception) through December 31, 2020 are not necessarily indicative of the results to be expected for
period ended September 30, 2021 or for any future periods.
The
Company had no activity for the period ended September 30, 2020 (inception). Accordingly, the condensed balance sheet as of September
30, 2020 is not presented.
Emerging
Growth Company
The
Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the
Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from
various reporting requirements that are applicable to other public companies that are not emerging growth companies including,
but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements
of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic
reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation
and stockholder approval of any golden parachute payments not previously approved.
Further,
Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial
accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared
effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised
financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and
comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The
Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and
it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the
new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s
financial statements with another public company which is neither an emerging growth company nor an emerging growth company which
has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting
standards used.
Use
of Estimates
The
preparation of the condensed financial statements in conformity with GAAP requires management to make estimates and assumptions
that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of
the financial statements and the reported amounts of revenues and expenses during the reporting period.
Making
estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect
of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered
in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual
results could differ significantly from those estimates.
DD3 ACQUISITION CORP. II
NOTES TO CONDENSED FINANCIAL STATEMENTS
DECEMBER 31, 2020
(Unaudited)
Cash
and Cash Equivalents
The
Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents.
The Company did not have any cash equivalents as of December 31, 2020.
Marketable
Securities Held in Trust Account
At
December 31, 2020, substantially all of the assets held in the Trust Account were held in U.S. Treasury Bills.
Class
A Common Stock Subject to Possible Redemption
The
Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in Accounting Standards
Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Shares of Class A common stock
subject to mandatory redemption is classified as a liability instrument and is measured at fair value. Conditionally redeemable
common stock (including common stock that features redemption rights that is either within the control of the holder or subject
to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary
equity. At all other times, common stock is classified as stockholders’ equity. The Company’s Class A common stock
features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence
of uncertain future events. Accordingly, at December 31, 2020, Class A common stock subject to possible redemption is presented
at redemption value as temporary equity, outside of the stockholders’ equity section of the Company’s condensed balance
sheet.
Income
Taxes
The
Company follows the asset and liability method of accounting for income taxes under ASC 740, “Income Taxes.” Deferred
tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial
statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities
are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are
expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized
in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred
tax assets to the amount expected to be realized.
FASB
ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement
of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more
likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties
related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for
interest and penalties as of December 31, 2020. The Company is currently not aware of any issues under review that could result
in significant payments, accruals or material deviation from its position.
The
Company may be subject to potential examination by federal, state and city taxing authorities in the areas of income taxes. These
potential examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions
and compliance with federal, state and city tax laws. The Company’s management does not expect that the total amount of
unrecognized tax benefits will materially change over the next twelve months.
Net
Loss Per Common Share
Net
loss per common share is computed by dividing net loss by the weighted average number of common shares outstanding for the
period. The Company applies the two-class method in calculating earnings per share. Shares of common stock subject to
possible redemption at December 31, 2020, which are not currently redeemable and are not redeemable at fair value, have been
excluded from the calculation of basic net loss per share since such shares, if redeemed, only participate in their pro rata
share of the Trust Account earnings. The Company has not considered the effect of warrants sold in the Initial Public
Offering and private placement to purchase 6,435,000 shares of Class A common stock in the calculation of diluted net loss
per share, since the exercise of the warrants is contingent upon the occurrence of future events. As a result, diluted net
loss per common share is the same as basic net loss per common share for the periods presented.
Concentration
of Credit Risk
Financial
instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution,
which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses
on this account.
DD3 ACQUISITION CORP. II
NOTES TO CONDENSED FINANCIAL STATEMENTS
DECEMBER 31, 2020
(Unaudited)
Fair
Value of Financial Instruments
The
fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair
Value Measurement,” approximates the carrying amounts represented in the condensed balance sheet, primarily due to their
short-term nature.
Recent
Accounting Standards
Management
does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material
effect on the Company’s condensed financial statements.
NOTE
3. INITIAL PUBLIC OFFERING
Pursuant
to the Initial Public Offering, the Company sold 12,500,000 Units, which includes a partial exercise by the underwriters of their
over-allotment option in the amount of 1,500,000 Units, at a price of $10.00 per Unit. Each Unit consists of one share of Class A
common stock and one-half of one redeemable warrant (“Public Warrant”). Each whole Public Warrant entitles the holder
to purchase one share of Class A common stock at a price of $11.50 per share, subject to adjustment (see Note 7).
NOTE
4. PRIVATE PLACEMENT
Simultaneously with
the closing of the Initial Public Offering, the Sponsor and the Forward Purchase Investors purchased an aggregate of 370,000 Private
Units at a price of $10.00 per Private Unit, for an aggregate purchase price of $3,700,000, in a private placement. The Sponsor
purchased an aggregate of 296,000 Private Units and Forward Purchase Investors purchased an aggregate of 74,000 Private Units.
Each Private Unit consists of one share of Class A common stock (“Private Share”) and one-half of one redeemable
warrant (“Private Warrant”). Each whole Private Warrant entitles the holder to purchase one share of Class A common
stock at a price of $11.50 per share, subject to adjustment (see Note 7). A portion of the proceeds from the Private Units were
added to the proceeds from the Initial Public Offering held in the Trust Account. The Private Units are identical to the Units
sold in the Initial Public Offering, except as described in Note 7. If the Company does not complete a Business Combination
within the Combination Period, the proceeds of the sale of the Private Units will be used to fund the redemption of the Public
Shares (subject to the requirements of applicable law) and underlying securities will be worthless.
Certain funds affiliated
with Baron Capital Group, Inc., which are members of the Sponsor, and MG Partners Multi-Strategy Fund LP (collectively, the “Forward
Purchase Investors”) have entered into contingent forward purchase agreements with the Company as described in Note 6.
NOTE
5. RELATED PARTY TRANSACTIONS
Founder
Shares
On October 13, 2020,
the Sponsor purchased 2,875,000 shares (the “Founder Shares”) of the Company’s Class B common stock for an aggregate
price of $25,000. On December 7, 2020, the Company effected a stock dividend of 287,500 shares with respect to the Class B common
stock, resulting in an aggregate of 3,162,500 Founder Shares issued and outstanding. All share and per-share amounts have been
retroactively restated to reflect the stock dividend effectuated on December 7, 2020. The Founder Shares included an aggregate
of up to 412,500 shares subject to forfeiture to the extent that the underwriters’ over-allotment option was not exercised
in full or in part, so that the initial stockholders would own, on an as-converted basis, 20.0% of the Company’s issued and
outstanding shares after the Initial Public Offering (excluding the Private Shares). As a result of the underwriters’ election
to partially exercise their over-allotment option, a total of 375,000 Founder Shares are no longer subject to forfeiture and 37,500
Founder Shares were forfeited, resulting in an aggregate of 3,125,000 Founder Shares issued and outstanding.
The
Company’s Sponsor, initial stockholders, officers and directors have agreed, subject to certain limited exceptions, not
to transfer, assign or sell any of the Founder Shares until the earlier of one year after the date of the consummation of a Business
Combination and the date on which the closing price of the Class A common stock equals or exceeds $12.50 per share (as adjusted
for stock splits, stock dividends, reorganizations and recapitalizations) for any 20 trading days within a 30-trading day period
commencing 150 days after a Business Combination, or earlier if, subsequent to a Business Combination, the Company completes a
liquidation, merger, stock exchange or other similar transaction which results in all of the Company’s stockholders having
the right to exchange their shares of common stock for cash, securities or other property.
Due
from Sponsor
As
of December 10, 2020, the Company advanced the Sponsor an aggregate of $25,000, which is included in prepaid expenses in the
accompanying condensed balance sheet.
DD3 ACQUISITION CORP. II
NOTES TO CONDENSED FINANCIAL STATEMENTS
DECEMBER 31, 2020
(Unaudited)
Administrative Services Agreement
The Company entered
into an agreement, commencing on December 7, 2020 through the earlier of the Company’s consummation of a Business Combination
and its liquidation, to pay the Sponsor a total of up to $10,000 per month for office space, utilities and administrative support.
For each of the three months ended December 31, 2020 and for the period from September 30, 2020 (inception) through December 31,
2020, the Company incurred $10,000 in fees for these services, which is included in accrued expenses in the accompanying condensed
balance sheet.
Promissory Note — Related Party
On October 13, 2020,
the Company issued an unsecured promissory note to the Sponsor (the “Promissory Note”), pursuant to which the Company
could borrow up to an aggregate principal amount of $150,000. The Promissory Note was non-interest bearing and payable on the earlier
of (i) March 31, 2021 or (ii) the consummation of the Initial Public Offering. The outstanding balance under the Promissory
Note of $105,747 was repaid at the closing of the Initial Public Offering on December 10, 2020.
Related
Party Loans
In
order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain
of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working
Capital Loans”). If the Company completes a Business Combination, the Company would repay the Working Capital Loans out
of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of
funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion
of proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would
be used to repay the Working Capital Loans. Except for the foregoing, the terms of such Working Capital Loans, if any, have not
been determined and no written agreements exist with respect to such loans. The Working Capital Loans would either be repaid upon
consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1,500,000 of such Working
Capital Loans may be convertible into units of the post-Business Combination entity at a price of $10.00 per unit. The units would
be identical to the Private Units.
NOTE
6. COMMITMENTS
Registration Rights Agreement
Pursuant to a registration
rights agreement entered into on December 7, 2020, the holders of the Founder Shares, Private Units, Private Shares, Private Warrants,
the units that may be issued upon conversion of Working Capital Loans, the shares of Class A common stock and the warrants issued
as part of such units (and any shares of Class A common stock issuable upon the exercise of the Private Warrants and warrants
included as part of the units that may be issued upon conversion of Working Capital Loans and upon conversion of the Founder Shares)
will be entitled to registration rights. The holders of a majority of these securities are entitled to make up to two demands that
the Company register such securities. The holders of the majority of the Founder Shares can elect to exercise these registration
rights at any time commencing three months prior to the date on which the Founder Shares are to be released from escrow. The holders
of a majority of the Private Units and units issued to the Sponsor, officers, directors, initial stockholders or their affiliates
in payment of Working Capital Loans made to the Company (or underlying securities) can elect to exercise these registration rights
at any time after the Company consummates a Business Combination. In addition, the holders have certain “piggy-back”
registration rights with respect to registration statements filed subsequent to the consummation of a Business Combination. The
registration rights agreement does not contain liquidated damages or other cash settlement provisions resulting from delays in
registering such securities. The Company will bear the expenses incurred in connection with the filing of any such registration
statements.
Underwriting
Agreement
The
underwriters were paid a cash underwriting discount of $0.20 per Unit, or $2,500,000 in the aggregate, payable upon the closing
of the Initial Public Offering.
Business Combination Marketing Agreement
The Company engaged the underwriters as
an advisor in connection with a Business Combination to assist the Company in holding meetings with its shareholders to discuss
the potential Business Combination and the target business’ attributes, introduce the Company to potential investors that
are interested in purchasing the Company’s securities in connection with a Business Combination, provide financial advisory
services to assist the Company in the Company’s efforts to obtain any stockholder approval for the Business Combination and
assist the Company with its press releases and public filings in connection with the Business Combination. The Company will pay
the underwriters a cash fee for such services upon the consummation of a Business Combination in an amount equal to, in the aggregate,
3.5% of the gross proceeds of Initial Public Offering (exclusive of any applicable finders’ fees which might become payable).
Forward Purchase Agreements
The Forward Purchase
Investors entered into contingent forward purchase agreements with the Company as of November 17, 2020 and November 19, 2020, which
provide for the purchase by the Forward Purchase Investors of an aggregate of up to 5,000,000 shares of Class A common stock, at
a price of $10.00 per share, for total gross proceeds of up to $50,000,000. These shares would be purchased in a private placement
to close simultaneously with the consummation of the Company’s Business Combination. These issuances would be made pursuant
to the exemption from registration contained in Section 4(a)(2) of the Securities Act.
DD3 ACQUISITION CORP. II
NOTES TO CONDENSED FINANCIAL STATEMENTS
DECEMBER 31, 2020
(Unaudited)
NOTE
7. STOCKHOLDERS’ EQUITY
Preferred
Stock — The Company is authorized to issue 1,000,000 shares of preferred stock with a par value of $0.0001 per share
with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s
board of directors. At December 31, 2020, there were no shares of preferred stock issued or outstanding.
Class A Common
Stock — The Company is currently authorized to issue up to 100,000,000 shares of Class A common stock with a par
value of $0.0001 per share. Holders of Class A common stock are entitled to one vote for each share. At December 31, 2020, there
were 802,865 shares of Class A common stock issued and outstanding, excluding 12,067,135 shares of Class A common stock subject
to possible redemption.
Class B Common
Stock — The Company is currently authorized to issue up to 10,000,000 shares of Class B common stock with a par value
of $0.0001 per share. Holders of Class B common stock are entitled to one vote for each share. At December 31, 2020, there were
3,125,000 shares of Class B common stock issued and outstanding.
Only holders of Class
B common stock have the right to vote on the election of directors prior to a Business Combination. Holders of Class A common
stock and Class B common stock will vote together as a single class on all other matters submitted to a vote of stockholders,
except as required by law.
The shares of Class
B common stock will automatically convert into shares of Class A common stock at the time of a Business Combination, or at any
time prior thereto at the option of the holder, on a one-for-one basis, subject to adjustment. In the case that additional shares
of Class A common stock, or equity-linked securities, are issued or deemed issued in excess of the amounts offered in the Initial
Public Offering and related to the closing of a Business Combination, the ratio at which shares of Class B common stock shall convert
into shares of Class A common stock will be adjusted (unless the holders of a majority of the outstanding shares of Class B common
stock agree to waive such adjustment with respect to any such issuance or deemed issuance) so that the number of shares of Class
A common stock issuable upon conversion of all shares of Class B common stock will equal, in the aggregate, on an as-converted
basis, 20% of the sum of the total number of all shares of common stock outstanding upon the completion of the Initial Public Offering
(not including the shares of Class A common stock underlying the Private Units) plus all shares of Class A common stock and equity-linked
securities issued or deemed issued in connection with a Business Combination (excluding any shares or equity-linked securities
issued, or to be issued, to any seller in a Business Combination and any additional units issued to the Sponsor, officers, directors,
initial stockholders or their affiliates in payment of Working Capital Loans made to the Company). The Company cannot determine
at this time whether a majority of the holders of the Class B common stock at the time of any future issuance would agree to waive
such adjustment to the conversion ratio.
Warrants —
Public Warrants may only be exercised for a whole number of shares. No fractional shares will be issued upon exercise of the Public
Warrants. The Public Warrants will become exercisable on the later of (a) 30 days after the consummation of a Business Combination
or (b) December 10, 2021. The Public Warrants will expire five years after the consummation of a Business Combination or earlier
upon redemption or liquidation.
The
Company may redeem the Public Warrants (excluding the Private Warrants and any warrants underlying units issued upon conversion
of the Working Capital Loans):
|
●
|
in
whole and not in part;
|
|
●
|
at
a price of $0.01 per warrant;
|
|
●
|
at
any time after the warrants become exercisable;
|
|
●
|
upon
not less than 30 days’ prior written notice of redemption to each warrant holder;
|
|
●
|
if,
and only if, the reported last sale price of the shares of Class A common stock equals or exceeds $18.00 per share (as adjusted
for stock splits, stock dividends, reorganizations and recapitalizations), for any 20 trading days within a 30 trading
day commencing at any time after the warrants become exercisable and ending on the third business day prior to the notice
of redemption to warrant holders; and
|
|
●
|
if,
and only if, there is a current registration statement in effect with respect to the shares of Class A common stock underlying
the warrants.
|
If
and when the warrants become redeemable by the Company, the Company may exercise its redemption right even if it is unable to
register or qualify the underlying securities for sale under all applicable state securities laws.
If
the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise
the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. The exercise price and
number of shares of Class A common stock issuable upon exercise of the warrants may be adjusted in certain circumstances
including in the event of a stock dividend, or recapitalization, reorganization, merger or consolidation. However, except as described
below, the warrants will not be adjusted for issuances of Class A common stock at a price below its exercise price. Additionally,
in no event will the Company be required to net cash settle the warrants. If the Company is unable to complete a Business Combination
within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive
any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held
outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless.
DD3 ACQUISITION CORP. II
NOTES TO CONDENSED FINANCIAL STATEMENTS
DECEMBER 31, 2020
(Unaudited)
In addition, if (x)
the Company issues additional shares of Class A common stock or equity-linked securities for capital raising purposes in connection
with the closing of its initial Business Combination at an issue price or effective issue price of less than $9.20 per share of
Class A common stock (with such issue price or effective issue price to be determined in good faith by the Company’s board
of directors and, in the case of any such issuance to the Sponsor, initial stockholders or their affiliates, without taking into
account any Founder Shares held by the Sponsor, initial stockholders or their affiliates, as applicable, prior to such issuance)
(the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total
equity proceeds, and interest thereon, available for the funding of the Company’s initial Business Combination on the date
of the consummation of such initial Business Combination (net of redemptions), and (z) the volume weighted average trading price
of the Class A common stock during the 20 trading day period starting on the trading day prior to the day on which the Company
consummates its initial Business Combination (such price, the “Market Value”) is below $9.20 per share, then the exercise
price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the greater of (i) the Market Value or (ii)
the Newly Issued Price, and the $18.00 per share redemption trigger price of the warrants will be adjusted (to the nearest cent)
to be equal to 180% of the greater of (i) the Market Value or (ii) the Newly Issued Price.
The Private Warrants
are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that the Private Warrants
and the shares of Class A common stock issuable upon the exercise of the Private Warrants will not be transferable, assignable
or salable until after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private
Warrants will be exercisable on a cashless basis and will be non-redeemable so long as they are held by the initial purchasers
or their permitted transferees. If the Private Warrants are held by someone other than the initial purchasers or their permitted
transferees, the Private Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public
Warrants.
NOTE
8. FAIR VALUE MEASUREMENTS
The
Company follows the guidance in ASC 820 for its financial assets and liabilities that are re-measured and reported at fair value
at each reporting period, and non-financial assets and liabilities that are re-measured and reported at fair value at least annually.
The
fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company
would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an
orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets
and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and
to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities).
The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable
inputs used in order to value the assets and liabilities:
|
Level 1:
|
Quoted
prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which
transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing
basis.
|
|
|
|
|
Level 2:
|
Observable
inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or
liabilities and quoted prices for identical assets or liabilities in markets that are not active.
|
|
|
|
|
Level 3:
|
Unobservable
inputs based on the Company’s assessment of the assumptions that market participants would use in pricing the asset
or liability.
|
The
following table presents information about the Company’s assets that are measured at fair value on a recurring basis at
December 31, 2020, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair
value:
Description
|
|
Level
|
|
December 31,
2020
|
|
Assets:
|
|
|
|
|
|
|
Marketable securities held in Trust Account
|
|
1
|
|
$
|
124,998,848
|
|
NOTE
9. SUBSEQUENT EVENTS
The
Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the condensed
financial statements were issued. Based upon this review, the Company did not identify any subsequent events that would have required
adjustment or disclosure in the condensed financial statements.